RLMD - Relmada Corp Bozor kapitallashuvining daromadga nisbati
Relmada Therapeutics (RLMD) kompaniyasining normallashtirilgan P/S ko'rsatkichi biznesning baholanish tendentsiyasini aks ettiradi va ushbu parametr qiymatiga yetdi. Relmada Therapeutics bioetik sinov standartlariga rioya qilish va laboratoriya ekologik barqarorligi orqali ESG tamoyillarini joriy etmoqda. O'zining noyob antidepressantlari uchun patent himoyasi premium narx belgilash imkoniyatini beradi. Keng qamrovli bozor potentsiali va klinik bosqichlarning yakunlanishi ushbu innovatsion terapiyaga kelgusida yuqori talab bo'lishini kafolatlaydi.
Relmada (RLMD) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi statistikasi:
- balans kapitallashuvi ko'rsatkichlari:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Qarzning kapitalga nisbati Relmada Therapeutics|RLMD - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Relmada Corp|RLMD - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar Relmada|RLMD - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli majburiyatlar Relmada Therapeutics|Shoshilinch likvidlik relmada.com
- foyda va bozor koeffitsiyentlari statistikasi:
RLMD - Sof daromad|Prognoz qilingan kelajakdagi foyda Relmada Therapeutics|RLMD - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning kelajakdagi foydaga nisbati Relmada Therapeutics Inc|RLMD - PEG multiplikatori|Kompaniyaning to‘liq qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Relmada|RLMD - EBITDA operatsion foydasi|So'nggi 12 oy davomida bir aksiya uchun sof foyda Relmada Therapeutics|RLMD - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik o'zgarishi relmada.com|RLMD - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi Relmada Therapeutics
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning umumiy tahlili:RLMD relmada.com
Relmada Therapeutics (RLMD) kompaniyasining baholanishi bevosita REL-1017 sinovlari natijalari va dori vositasining xavfsizlik profiliga bog'liq. Tarixiy P/S koeffitsiyenti joriy savdo hajmlariga nisbatan bozor kapitalizatsiyasini ko'rsatadi. ning joriy qiymati aksiya narxi va tushumlar o'rtasidagi nisbatni aks ettirib, kelajakdagi muvaffaqiyat uchun to'langan premium darajasini o'lchaydi. Ushbu koeffitsiyentning keskin tebranishlari mahsulotning tijoratlashtirilishiga oid investorlar kutganlarini o'zgarishidan dalolat beradi.
Relmada Therapeutics raqobatchilari
P/S multiplikatori biogen.com (BIIB)|Neurocrine Biosciences, Inc. - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati RGC|AXSM: Kapitalizatsiyaning daromadga nisbati|ACADIA Corp - Kapitalizatsiyaning sotish hajmiga nisbati|XENE: P/S multiplikatori|vikingtherapeutics.com - Bozor kapitallashuvining daromadga nisbati|SUPN (Supernus) - P/S multiplikatori|Sotuvga nisbatan narx Catalyst Pharma CPRX|Narxning daromadga nisbati Denali Therapeutics Inc (DNLI)|HRMY (Harmony Corp) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori BHVN (Biohaven Ltd.)|P/S multiplikatori amylyx.com AMLX|TRVI - Narxning daromadga nisbati|Narxning sotuvga nisbati PRAX|AVXL: P/S multiplikatori|Sotuvga nisbatan narx CeriBell EEG (CBLL)|Kapitalizatsiyaning daromadga nisbati PRTA|P/S multiplikatori Alector Therapeutics|Kapitalizatsiyaning daromadga nisbati ANNX (Annexon)|Kapitalizatsiyaning sotish hajmiga nisbati OMER|P/S multiplikatori NGNE (Neurogene Corp)|Narx/daromad koeffitsiyenti AC Immune Inc (ACIU)|Voyager Therapeutics - P/S multiplikatori|neumoratx.com (NMRA) - Kapitalizatsiyaning daromadga nisbati|Scilex (SCLX) - Narxning daromadga nisbati|TVGN - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Alpha Cognition Inc|CGTX: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Inhibikase Therapeutics (IKT)|Narxning daromadga nisbati SAVA (cassavasciences.com)|Narxning daromadga nisbati Assertio ASRT|COYA - Kapitalizatsiyaning daromadga nisbati|VistaGen Therapeutics Inc - P/S multiplikatori|OVID (Ovid Therapeutics Inc.) - Kapitalizatsiya va daromad nisbati|Acumen Pharmaceuticals (ABOS) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati CRVO|ATHE (Alterity Therapeutics Ltd.) - P/S multiplikatori|Sotuvga nisbatan narx Clene Nanomedicine CLNN|Kapitalizatsiyaning daromadga nisbati PEPG (PepGen Inc.)|P/S multiplikatori Jupiter Neurosciences, Inc. (JUNS)|Narxning daromadga nisbati Annovis Bio, Inc. ANVS|Bozor kapitallashuvining daromadga nisbati GRCE|AIFF - Narxning daromadga nisbati|Sotuvga nisbatan narx Klotho Neurosciences Inc|neurosense-tx.com (NRSN) - Narxning daromadga nisbati|Reviva Pharmaceuticals, Inc. - Bozor kapitallashuvining daromadga nisbati|MTVA (MetaVia Inc.) - P/S multiplikatori|Sotuvga nisbatan narx neuraxis.com NRXS|Narxning daromadga nisbati Helius Medical (HSDT)|Narxning daromadga nisbati PASG (passagebio.com)|Narxning daromadga nisbati Neuphoria Therapeutics NEUP|NERV - Kapitalizatsiyaning daromadga nisbati|Athira Pharma, Inc. - P/S multiplikatori|ADXN - P/S multiplikatori|ALZN: P/S multiplikatori|Kapitalizatsiya va daromad nisbati CYCN|PTIX (Protagenic Therapeutics Inc.) - P/S multiplikatori|P/S multiplikatori Pasithea|Kapitalizatsiyaning daromadga nisbati CRGT (Cortigent, Inc.)|ATXI (avenuetx.com) - Bozor kapitallashuvining daromadga nisbati|BrainStorm Cell Therapeutics - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati CARA (Cara Therapeutics Inc.)|Chromocell Therapeutics Corporation - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati ELYM (Eliem Therapeutics)|ITCI: P/S multiplikatori|Sotuvga nisbatan narx longboardpharma.com (LBPH)|Narxning daromadga nisbati Marinus Pharmaceuticals, Inc.|NKGN: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori NRBO|P/S multiplikatori Sage Therapeutics Inc (SAGE)|Narxning daromadga nisbati Synaptogenix, Inc. SNPX|TRVN (trevena.com) - Narxning sotuvga nisbati|Vigil Neuro - P/S multiplikatori|Sotuvga nisbatan narx anewmeds.com|CERE (Cerevel) - Kapitalizatsiyaning daromadga nisbati
